143 related articles for article (PubMed ID: 11774131)
1. Malignancy after renal transplantation.
Zeier M; Hartschuh W; Wiesel M; Lehnert T; Ritz E
Am J Kidney Dis; 2002 Jan; 39(1):E5. PubMed ID: 11774131
[TBL] [Abstract][Full Text] [Related]
2. Malignancy and chronic renal failure.
Peces R
Saudi J Kidney Dis Transpl; 2003; 14(1):5-14. PubMed ID: 17657083
[TBL] [Abstract][Full Text] [Related]
3. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
[TBL] [Abstract][Full Text] [Related]
4. [Post-transplantation malignant tumors and the challenges of immunosuppressive therapy in transplanted patients developing lymphoma. Mycophenolic acid as a possibility].
Végso G
Magy Onkol; 2009 Jun; 53(2):149-56. PubMed ID: 19581181
[TBL] [Abstract][Full Text] [Related]
5. Urological malignancy after renal transplantation.
Besarani D; Cranston D
BJU Int; 2007 Sep; 100(3):502-5. PubMed ID: 17669141
[TBL] [Abstract][Full Text] [Related]
6. Malignancy incidence after renal transplantation in children: a 20-year single-centre experience.
Koukourgianni F; Harambat J; Ranchin B; Euvrard S; Bouvier R; Liutkus A; Cochat P
Nephrol Dial Transplant; 2010 Feb; 25(2):611-6. PubMed ID: 19820249
[TBL] [Abstract][Full Text] [Related]
7. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
[TBL] [Abstract][Full Text] [Related]
8. [Malignant neoplasias in renal transplantation recipients].
Gómez-Roel X; León-Rodríguez E
Rev Invest Clin; 2005; 57(2):225-9. PubMed ID: 16524062
[TBL] [Abstract][Full Text] [Related]
9. Malignancies after kidney transplantation.
Rascente M; Pisani F; Barletta A; D'Angelo M; Giammaria A; Parzanese I; Rizza V; Iaria G; Famulari A
Transplant Proc; 2005; 37(6):2529-31. PubMed ID: 16182735
[TBL] [Abstract][Full Text] [Related]
10. [Tumors and kidney transplantation].
Brünisholz M; Hodel K; Brunner FP; Harder F; Torhorst J; Thiel G
Schweiz Med Wochenschr; 1984 Dec; 114(51):1915-24. PubMed ID: 6395328
[TBL] [Abstract][Full Text] [Related]
11. [De novo malignancy following renal transplantation].
Suzuki S; Osaka Y; Nakai I; Yasumura T; Omori Y; Oka T
Nihon Geka Gakkai Zasshi; 1994 Nov; 95(11):834-7. PubMed ID: 7830710
[TBL] [Abstract][Full Text] [Related]
12. Cancer incidence and survival in kidney transplant patients.
Navarro MD; López-Andréu M; Rodríguez-Benot A; Agüera ML; Del Castillo D; Aljama P
Transplant Proc; 2008 Nov; 40(9):2936-40. PubMed ID: 19010153
[TBL] [Abstract][Full Text] [Related]
13. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.
Saigal S; Norris S; Muiesan P; Rela M; Heaton N; O'Grady J
Liver Transpl; 2002 May; 8(5):482-7. PubMed ID: 12004349
[TBL] [Abstract][Full Text] [Related]
14. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.
Wolfe RA; Ashby VB; Milford EL; Ojo AO; Ettenger RE; Agodoa LY; Held PJ; Port FK
N Engl J Med; 1999 Dec; 341(23):1725-30. PubMed ID: 10580071
[TBL] [Abstract][Full Text] [Related]
15. Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study.
Tessari G; Naldi L; Boschiero L; Nacchia F; Fior F; Forni A; Rugiu C; Faggian G; Sassi F; Gotti E; Fiocchi R; Talamini G; Girolomoni G
Arch Dermatol; 2010 Mar; 146(3):294-9. PubMed ID: 20231501
[TBL] [Abstract][Full Text] [Related]
16. Malignancies in renal transplantation: an unmet medical need.
Dantal J; Pohanka E
Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i4-10. PubMed ID: 17456618
[TBL] [Abstract][Full Text] [Related]
17. Cancer incidence after immunosuppressive treatment following kidney transplantation.
Andrés A
Crit Rev Oncol Hematol; 2005 Oct; 56(1):71-85. PubMed ID: 15978827
[TBL] [Abstract][Full Text] [Related]
18. Conversion to rapamycin immunosuppression for malignancy after kidney transplantation.
Manuelli M; De Luca L; Iaria G; Tatangelo P; Sforza D; Perrone L; Bellini MI; Angelico R; Anselmo A; Tisone G
Transplant Proc; 2010 May; 42(4):1314-6. PubMed ID: 20534289
[TBL] [Abstract][Full Text] [Related]
19. Malignancies after kidney transplantation: a 40-year single-center experience in Korea.
Hwang JK; Moon IS; Kim JI
Transpl Int; 2011 Jul; 24(7):716-21. PubMed ID: 21575081
[TBL] [Abstract][Full Text] [Related]
20. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors.
Kelly DM; Emre S; Guy SR; Miller CM; Schwartz ME; Sheiner PA
Cancer; 1998 Sep; 83(6):1237-43. PubMed ID: 9740091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
